Crossmark

BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion

Crossref DOI link: https://doi.org/10.1186/s12943-022-01516-w

Published Online: 2022-02-22

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Lu

Cheng, Xianfeng

Yang, Hui

Lian, Senlin

Jiang, Yuegen

Liang, Jinhua

Chen, Xiao

Mo, Suo

Shi, Yu

Zhao, Sishu

Li, Jianyong

Jiang, Runqiu

Yang, Dong-Hua https://orcid.org/0000-0001-8649-5531
Wu, Yujie
License Information

Text and Data Mining valid from 2022-02-22

Version of Record valid from 2022-02-22
More Information

Article History

Received: 30 November 2021

Accepted: 21 January 2022

First Online: 22 February 2022

Declarations

:

: This study was approved by the Ethics Committee of the Jiangsu Province Hospital (2018-SRFA-087), and written informed consent was obtained from all patients according to the Declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below